SUPPLEMENT
Q2 2022 — Financial statement information
Q2 2022PDF · 13 pages238 KB
Three months ended June 30, Six months ended June 30, 2022 2021 2022 2021 Net sales $ 8,702 $ 8,950 $ 17,531 $ 17,801 Operating expenses Cost of sales 5,093 4,719 9,919 9,244 Selling, general and administrative expenses 3,023 1,746 4,905 3,554 Research, development and related expenses 476 514 956 1,038 Total operating expenses 8,592 6,979 15,780 13,836 Operating income 110 1,971 1,751 3,965 Other expense (income), net 50 33 88 82 Income before income taxes 60 1,938 1,663 3,883 Provision for income taxes (23) 415 279 734 Income of consolidated group 83 1,523 1,384 3,149 Income (loss) from unconsolidated subsidiaries, net of taxes (1) 2 1 3 Net income including noncontrolling interest 82 1,525 1,385 3,152 Less: Net income (loss) attributable to noncontrolling interest 4 1 8 4 Net income attributable to 3M $ 78 $ 1,524 $ 1,377 $ 3,148 Weighted average 3M common shares outstanding – basic 571.0 581.0 571.6 580.7 Earnings per share attributable to 3M common shareholders – basic $ 0.14 $ 2.62 $ 2.41 $ 5.42 Weighted average 3M common shares outstanding – diluted 572.7 588.6 573.8 587.4 Earnings per share attributable to 3M common shareholders – diluted $ 0.14 $ 2.59 $ 2.40 $ 5.36 3M Company and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (Millions, except per-share amounts) (Unaudited) -- 1 of 13 -- June 30, 2022 December 31, 2021 ASSETS Current assets Cash and cash equivalents $ 2,722 $ 4,564 Marketable securities – current 262 201 Accounts receivable – net 4,914 4,660 Inventories 5,645 4,985 Prepaids 588 654 Other current assets 383 339 Total current assets 14,514 15,403 Property, plant and equipment – net 9,319 9,429 Operating lease right of use assets 835 858 Goodwill and intangible assets – net 18,057 18,774 Other assets 2,909 2,608 Total assets $ 45,634 $ 47,072 LIABILITIES AND EQUITY Current liabilities Short-term borrowings and current portion of long-term debt $ 2,257 $ 1,307 Accounts payable 3,273 2,994 Accrued payroll 704 1,020 Accrued income taxes 228 260 Operating lease liabilities – current 256 263 Other current liabilities 3,178 3,191 Total current liabilities 9,896 9,035 Long-term debt 14,019 16,056 Other liabilities 7,903 6,864 Total liabilities 31,818 31,955 Total equity 13,816 15,117 Shares outstanding June 30, 2022: 569,603,928 December 31, 2021: 571,845,478 Total liabilities and equity $ 45,634 $ 47,072 3M Company and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEET (Dollars in millions) (Unaudited) -- 2 of 13 -- Six months ended June 30, 2022 2021 NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 2,138 $ 3,575 Cash flows from investing activities: Purchases of property, plant and equipment (808) (704) Purchases and proceeds from sale or maturities of marketable securities and investments – net (62) (402) Proceeds from sale of businesses, net of cash sold 13 — Other investing activities 43 63 NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (814) (1,043) Cash flows from financing activities: Change in debt (834) (445) Purchases of treasury stock (773) (734) Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 227 480 Dividends paid to shareholders (1,700) (1,716) Other financing activities (22) (19) NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (3,102) (2,434) Effect of exchange rate changes on cash and cash equivalents (64) (37) Net increase (decrease) in cash and cash equivalents (1,842) 61 Cash and cash equivalents at beginning of year 4,564 4,634 Cash and cash equivalents at end of period $ 2,722 $ 4,695 3M Company and Subsidiaries CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Dollars in millions) (Unaudited) -- 3 of 13 -- Operating Income (Loss) Net Income Attrib- utable to 3M Year- over- year earnings per diluted share percent change (Dollars in millions, except per share amounts) Safety and Industrial Safety and Industrial Margin Total Company Total Company Margin Income Before Taxes Provision for Income Taxes Effective Tax Rate Earnings per Diluted Share Three months ended June 30, 2021 GAAP $ 662 21.8 % $ 1,971 22.0 % $ 1,938 $ 415 21.5 % $ 1,524 $ 2.59 Adjustments for special items: Net costs for significant litigation 52 127 127 30 97 0.16 Three months ended June 30, 2021 adjusted amounts (non- GAAP measures) (a) $ 714 23.6 % $ 2,098 23.4 % $ 2,065 $ 445 21.6 % $ 1,621 $ 2.75 Three months ended June 30, 2022 GAAP $ (707) (24.2) % $ 110 1.3 % $ 60 $ (23) (38.3) % $ 78 $ 0.14 (95) % Adjustments for special items: Net costs for significant litigation 1,337 1,716 1,716 374 1,342 2.34 Three months ended June 30, 2022 adjusted amounts (non- GAAP measures) (a) 630 21.5 % $ 1,826 21.0 % $ 1,776 $ 351 19.8 % $ 1,420 $ 2.48 (10) % Six months ended June 30, 2021 GAAP 1,414 23.1 % $ 3,965 22.3 % $ 3,883 $ 734 18.9 % $ 3,148 $ 5.36 Adjustments for special items: Net costs for significant litigation 117 $ 262 $ 262 $ 62 $ 200 $ 0.34 Six months ended June 30, 2021 adjusted amounts (non-GAAP measures) (a) 1,531 25.0 % $ 4,227 23.7 % $ 4,145 $ 796 19.2 % $ 3,348 $ 5.70 Six months ended June 30, 2022 GAAP (71) (1.2) % $ 1,751 10.0 % $ 1,663 $ 279 16.8 % $ 1,377 $ 2.40 (55) % Adjustments for special items: Net costs for significant litigation 1,400 $ 1,966 $ 1,966 $ 399 $ 1,567 $ 2.73 Six months ended June 30, 2022 adjusted amounts (non-GAAP measures) (a) 1,329 22.2 % $ 3,717 21.2 % $ 3,629 $ 678 18.7 % $ 2,944 $ 5.13 (10) % (Dollars in millions, except per share amounts) Full Year 2022 Forecast Earnings per share 2022 GAAP earnings per share (GAAP)* $ 7.32 to $ 7.82 Adjustments for estimated special items: Pre-tax Net costs for significant litigation ~$2,150 $2.98 Divestiture costs* — — 2022 adjusted earnings per share amounts (non-GAAP measures) (a) $ 10.30 to $ 10.80 * 3M does not include projected divestiture gains and the impact potentially-divested businesses may have on expected operations in its forecasted outlook guidance until close of a transaction as these items have not yet occurred and generally involve certain conditions that are outside of 3M’s control. Additionally, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures. These items include, but are not limited to, divestiture costs in light of the fact that such items are difficult to predict in advance to include in a GAAP estimate. This is due to limitations in predicting the meaningful amount and timing of costs involved over the duration of an announced segment-sized deal, including factors outside of 3M’s control, and 3M believes would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. __________________________ 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) -- 4 of 13 -- (a) In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides non-GAAP measures that adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of Special Items”. Operating income (loss), segment operating income (loss), income before taxes, net income, earnings per share, and the effective tax rate are all measures for which 3M provides the reported GAAP measure and a measure adjusted for special items. The adjusted measures are not in accordance with, nor are they a substitute for, GAAP measures. While the Company includes certain items in its measure of segment operating performance, it also considers these non-GAAP measures in evaluating and managing its operations. The Company believes that discussion of results adjusted for special items is useful to investors in understanding underlying business performance, while also providing additional transparency to the special items. Special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as described with respect to net costs for significant litigation in the “Description of Special Items” section. The determination of these items may not be comparable to similarly titled measures used by other companies. In the first quarter of 2022, the Company changed the extent of matters and charges/benefits it includes within special items with respect to net costs for significant litigation. Previously, 3M included net costs, when significant, associated with changes in accrued liabilities related to respirator mask/asbestos litigation and PFAS-related other environmental matters, along with the associated tax impacts. The non-GAAP measure changes involved including net costs for litigation related to 3M's Combat Arms Earplugs, expanding net costs to include external legal fees and insurance recoveries associated with the applicable matters in addition to changes in accrued liabilities, and to include all such net costs for the applicable matters, not just when considered significant. The information provided herein reflects the impacts of these changes for all periods presented. Three months ended June 30, Six months ended June 30, Major GAAP Cash Flow Categories (dollars in millions) 2022 2021 2022 2021 Net cash provided by (used in) operating activities $ 1,127 $ 1,887 $ 2,138 $ 3,575 Net cash provided by (used in) investing activities (551) (674) (814) (1,043) Net cash provided by (used in) financing activities (1,048) (1,183) (3,102) (2,434) Major GAAP Cash Flow Categories (dollars in billions) Full-Year 2022 Forecast Net cash provided by (used in) operating activities* $6.6 to $7.2 Purchase of property, plant and equipment ($1.7 to $2.0) Free cash flow $4.6 to $5.5 Adjustments for special items: Net costs for significant litigation after-tax payment impacts ~$0.6 Divestiture costs* — TCJA transition tax payment ~$0.1 Adjusted free cash flow (b) $5.3 to $6.2 Net income attributable to 3M* $4.2 to $4.5 Adjustments for special items: Net costs for significant litigation ~$1.7 Divestiture costs* — Adjusted net income attributable to 3M (a) $5.9 to $6.2 Adjusted free cash flow conversion (b) 90% to 100% * 3M does not include projected divestiture gains and the impact potentially-divested businesses may have on expected operations in its forecasted outlook guidance until close of a transaction as these items have not yet occurred and generally involve certain conditions that are outside of 3M’s control. Additionally, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures. These items include, but are not limited to, divestiture costs in light of the fact that such items are difficult to predict in advance to include in a GAAP estimate. This is due to limitations in predicting the meaningful amount and timing of costs and payments involved over the duration of an announced segment-sized deal, including factors outside of 3M’s control, and 3M believes would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 5 of 13 -- Three months ended June 30, Six months ended June 30, Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2022 2021 2022 2021 Net cash provided by (used in) operating activities $ 1,127 $ 1,887 $ 2,138 $ 3,575 Purchases of property, plant and equipment (384) (394) (808) (704) Free cash flow 743 1,493 1,330 2,871 Adjustments for special items: Net costs for significant litigation after-tax payment impacts 160 70 288 120 TCJA transition tax payment 68 68 68 77 Divestiture-related restructuring after-tax payment impacts — 3 — 4 Adjusted free cash flow (b) 971 1,634 1,686 3,072 Net income attributable to 3M $ 78 $ 1,524 $ 1,377 $ 3,148 Adjustments for special items: Net costs for significant litigation 1,342 97 1,567 200 Adjusted net income attributable to 3M (a) $ 1,420 $ 1,621 $ 2,944 $ 3,348 Adjusted free cash flow conversion (b) 68 % 101 % 57 % 92 % ______________________________________ (b) Adjusted free cash flow and adjusted free cash flow conversion are not defined under U.S. GAAP. Therefore, they should not be considered a substitute for income or cash flow data prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted free cash flow as net cash provided by operating activities, adjusted for special items, less purchases of property, plant and equipment. Cash payments associated with special items in the determination of adjusted free cash flow are reflected net of applicable tax using the U.S. statutory corporate tax rate during the period of payment. It should not be inferred that the entire adjusted free cash flow amount is available for discretionary expenditures. The Company defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items. Special items for the periods presented include the items described in section entitled “Description of Special Items”. The Company believes adjusted free cash flow and adjusted free cash flow conversion are meaningful to investors as they are useful measures of performance and the Company uses these measures as an indication of the strength of the company and its ability to generate cash. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 6 of 13 -- Adjusted EBITDA (non-GAAP measure) (c) Adjusted EBITDA Margin (non-GAAP measure) (c) Three months ended June 30, Six months ended June 30, Three months ended June 30, Six months ended June 30, (Dollars in millions) 2022 2021 2022 2021 2022 2021 2022 2021 Safety and Industrial $ 774 $ 864 $ 1,617 $ 1,822 26.5 % 28.5 % 27.1 % 29.7 % Transportation and Electronics 578 616 1,175 1,271 25.4 % 26.2 % 25.5 % 26.7 % Health Care 648 709 1,252 1,331 29.7 % 32.8 % 29.1 % 31.5 % Consumer 284 327 545 630 21.4 % 23.3 % 20.6 % 23.4 % Corporate and Unallocated 4 54 49 105 Total Company $ 2,288 $ 2,570 $ 4,638 $ 5,159 26.3 % 28.7 % 26.5 % 29.0 % Three months ended June 30, Six months ended June 30, Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2022 2021 2022 2021 Net sales $ 8,702 $ 8,950 $ 17,531 $ 17,801 Net income attributable to 3M 78 1,524 1,377 3,148 Add/(subtract): Net income/(loss) attributable to noncontrolling interest 4 1 8 4 (Income)/loss from unconsolidated subsidiaries, net of taxes 1 (2) (1) (3) Provision for income taxes (23) 415 279 734 Other expense/(income): Interest (Income)/expense 117 113 222 241 Pension & OPEB non-service cost (benefit) (67) (80) (134) (159) Depreciation and amortization expense 462 472 921 932 Adjustments for special items: Net costs for significant litigation 1,716 127 1,966 262 Adjusted EBITDA (c) $ 2,288 $ 2,570 $ 4,638 $ 5,159 Adjusted EBITDA margin (c) 26.3 % 28.7 % 26.5 % 29.0 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 7 of 13 -- Adjusted EBITDA (non-GAAP measure) Three months ended June 30, 2022 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 2,924 $ 2,268 $ 2,179 $ 1,330 $ 1 $ 8,702 Business segment operating income (loss) (measure of segment operating performance) $ (707) $ 476 $ 494 $ 247 $ (400) $ 110 Add/(subtract): Depreciation and amortization 144 102 154 37 25 462 Adjustments for special items: Net costs for significant litigation 1,337 379 1,716 Adjusted EBITDA (non-GAAP measure) (c) $ 774 $ 578 $ 648 $ 284 $ 4 $ 2,288 Adjusted EBITDA margin (non-GAAP measure) (c) 26.5 % 25.4 % 29.7 % 21.4 % 26.3 % Adjusted EBITDA (non-GAAP measure) Three months ended June 30, 2021 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 3,029 $ 2,355 $ 2,165 $ 1,400 $ 1 $ 8,950 Business segment operating income (measure of segment operating performance) $ 662 $ 513 $ 548 $ 290 $ (42) $ 1,971 Add/(subtract): Depreciation and amortization 150 103 161 37 21 472 Adjustments for special items: Net costs for significant litigation 52 75 127 Adjusted EBITDA (non-GAAP measure) (c) $ 864 $ 616 $ 709 $ 327 $ 54 $ 2,570 Adjusted EBITDA margin (non-GAAP measure) (c) 28.5 % 26.2 % 32.8 % 23.3 % 28.7 % Adjusted EBITDA (non-GAAP measure) Six months ended June 30, 2022 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 5,975 $ 4,608 $ 4,303 $ 2,643 $ 2 $ 17,531 Business segment operating income (loss) (measure of segment operating performance) $ (71) $ 972 $ 942 $ 471 $ (563) $ 1,751 Add/(subtract): Depreciation and amortization 288 203 310 74 46 921 Adjustments for special items: Net costs for significant litigation 1,400 566 1,966 Adjusted EBITDA (non-GAAP measure) (c) $ 1,617 $ 1,175 $ 1,252 $ 545 $ 49 $ 4,638 Adjusted EBITDA margin (non-GAAP measure) (c) 27.1 % 25.5 % 29.1 % 20.6 % 26.5 % Adjusted EBITDA (non-GAAP measure) Six months ended June 30, 2021 (dollars in millions) Safety and Industrial Transportation and Electronics Health Care Consumer Corporate and Unallocated Total Company Net sales $ 6,128 $ 4,751 $ 4,234 $ 2,689 $ (1) $ 17,801 Business segment operating income (measure of segment operating performance) $ 1,414 $ 1,069 $ 1,012 $ 559 $ (89) $ 3,965 Add/(subtract): Depreciation and amortization 291 202 319 71 49 932 Adjustments for special items: Net costs for significant litigation 117 145 262 Adjusted EBITDA (non-GAAP measure) (c) $ 1,822 $ 1,271 $ 1,331 $ 630 $ 105 $ 5,159 Adjusted EBITDA margin (non-GAAP measure) (c) 29.7 % 26.7 % 31.5 % 23.4 % 29.0 % ______________________________________ 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 8 of 13 -- (c) Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP. Therefore, adjusted EBITDA and adjusted EBITDA margin should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest, (income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. For business segments, the Company defines adjusted EBITDA as business segment operating income (loss) (3M’s measure of segment operating performance) adjusted for depreciation and amortization expense and special items. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales. Special items for the periods presented include the items described in the section entitled “Description of Special Items”. The Company considers these non-GAAP measures in evaluating and managing the Company’s operations. The Company believes adjusted EBITDA and adjusted EBITDA margin are meaningful to investors as they provide useful analyses of ongoing underlying operating trends. Net Debt (non-GAAP measure) June 30, 2022 December 31, 2021 Total debt $ 16,276 $ 17,363 Less: Cash, cash equivalents and marketable securities 3,011 4,792 Net debt (d) $ 13,265 $ 12,571 ______________________________________ (d) Net debt is not defined under U.S. GAAP and may not be computed the same as similarly titled measures used by other companies. The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities. 3M believes net debt is meaningful to investors as 3M considers net debt and its components to be an important indicator of liquidity and a guiding measure of capital structure strategy. Description of Special Items: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos, PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities, external legal fees, and insurance recoveries, along with the associated tax impacts. Net costs related to respirator mask/asbestos and Combat Arms Earplugs matters are reflected as special items in the Safety and Industrial business segment while those associated with PFAS-related other environmental matters are primarily reflected as corporate special items in Corporate and Unallocated. In the second quarter of 2022 and 2021, 3M made payments of approximately $202 million and $90 million, respectively, related to net costs for significant litigation. In the first six months of 2022 and 2021, 3M made payments of approximately $363 million and $153 million, respectively, related to net costs for significant litigation. Divestiture costs: • These include costs related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. Gain/loss on sale of businesses: • There were no gains/losses on sales of businesses for the periods presented. Additionally, 3M does not include expected gains on divestitures in its forecasted outlook guidance as these items have not yet occurred and generally involve certain conditions that are outside of 3M’s control. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 9 of 13 -- Divestiture-related restructuring actions: • In the second quarter of 2021, 3M made payments of approximately $4 million associated with divestiture-related restructuring actions. In the first six months of 2022 and 2021, 3M made payments of approximately $1 million and $5 million, respectively, associated with divestiture-related restructuring actions. Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA) • In the second quarter of 2022 and 2021, 3M made payments of approximately $68 million and $68 million, respectively, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. In the first six months of 2022 and 2021, 3M made payments of approximately $68 million and $77 million, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) -- 10 of 13 -- Three months ended June 30, 2022 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 3.9 % (1.8) % (2.0) % 1.0 % Divestitures — — — — Translation (0.2) (6.0) (10.2) (3.8) Total sales change 3.7 % (7.8) % (12.2) % (2.8) % Six months ended June 30, 2022 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 3.2 % 0.5 % (2.0) % 1.4 % Divestitures — — — — Translation (0.1) (4.3) (7.9) (2.9) Total sales change 3.1 % (3.8) % (9.9) % (1.5) % Three months ended June 30, 2022 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial 0.7 % — % — % (4.1) % (3.4) % Transportation and Electronics 0.5 — — (4.2) (3.7) Health Care 4.4 — — (3.8) 0.6 Consumer (2.5) — — (2.5) (5.0) Total Company 1.0 — — (3.8) (2.8) Six months ended June 30, 2022 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial 0.6 % — % — % (3.1) % (2.5) % Transportation and Electronics 0.1 — — (3.1) (3.0) Health Care 4.5 — — (2.9) 1.6 Consumer 0.3 — — (2.0) (1.7) Total Company 1.4 — — (2.9) (1.5) ______________________________________ (e) Total sales change is calculated based on reported sales results. The components of sales change include organic local- currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction. 3M Company and Subsidiaries SALES CHANGE ANALYSIS (e) (Unaudited) -- 11 of 13 -- 3M discloses business segment operating income as its measure of segment profit/loss, reconciled to both total 3M operating income and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Unallocated”). Effective in the first quarter of 2022, the measure of segment operating performance used by 3M’s chief operating decision maker (CODM) changed and, as a result, 3M’s disclosed measure of segment profit/loss (business segment operating income) was updated. The change to business segment operating income aligns with the update to how the CODM assesses performance and allocates resources for the Company’s business segments. The changes included the items described below. The financial information presented herein reflects the impact of these business segment reporting changes for all periods presented. Eliminating inclusion of dual credit in measure of segment operating performance 3M business segment operating performance measures were updated to no longer include dual credit to business segments for certain sales and related operating income. Management previously evaluated its business segments based on net sales and operating income performance, including dual credit reporting. 3M reflected additional (“dual”) credit to another business segment when the customer account activity (“sales district”) with respect to the particular product sold to the external customer was provided by a different business segment. For example, privacy screen protection products are primarily sold by the Display Materials and Systems Division within the Transportation and Electronics business segment; however, certain sales districts within the Consumer business segment provide the customer account activity for sales of the product to particular customers. In this example, the non-primary selling segment (Consumer) previously would also have received credit for the associated net sales initiated through its sales district and the related approximate operating income. The offset to the dual credit business segment reporting was reflected as a reconciling item entitled “Elimination of Dual Credit,” such that sales and operating income in total were unchanged. Reflecting certain litigation-related costs in the Safety and Industrial segment's operating performance measure 3M's business segment operating performance measure with respect to its Safety and Industrial business segment was updated relative to litigation-related costs for respirator mask/asbestos litigation matters. Previously, 3M included these costs, when significant, as a special item within Corporate and Unallocated. 3M now includes all litigation-related costs associated with respirator mask/asbestos litigation matters within the Safety and Industrial business segment (along with other Safety and Industrial matters already included therein, such as those related to Combat Arms Earplugs). BUSINESS SEGMENT INFORMATION Three months ended June 30, Six months ended June 30, NET SALES (Millions) 2022 2021 2022 2021 Safety and Industrial $ 2,924 $ 3,029 $ 5,975 $ 6,128 Transportation and Electronics 2,268 2,355 4,608 4,751 Health Care 2,179 2,165 4,303 4,234 Consumer 1,330 1,400 2,643 2,689 Corporate and Unallocated 1 1 2 (1) Total Company $ 8,702 $ 8,950 $ 17,531 $ 17,801 3M Company and Subsidiaries BUSINESS SEGMENTS (Unaudited) -- 12 of 13 -- BUSINESS SEGMENT INFORMATION Three months ended June 30, Six months ended June 30, OPERATING INCOME (LOSS) (Millions) 2022 2021 2022 2021 Safety and Industrial $ (707) $ 662 $ (71) $ 1,414 Transportation and Electronics 476 513 972 1,069 Health Care 494 548 942 1,012 Consumer 247 290 471 559 Total business segment operating income (loss) 510 2,013 2,314 4,054 Corporate and Unallocated Corporate special items: Net costs for significant litigation (379) (75) (566) (145) Other corporate expense - net (21) 33 3 56 Total Corporate and Unallocated (400) (42) (563) (89) Total Company operating income 110 1,971 1,751 3,965 Other expense/(income), net 50 33 88 82 Income before income taxes $ 60 $ 1,938 $ 1,663 $ 3,883 Corporate and Unallocated Corporate and Unallocated operating income includes “corporate special items” and “other corporate expense-net”. Corporate special items include net costs for significant litigation associated with PFAS-related other environmental matters, gain/loss on sale of businesses, and divestiture-related restructuring costs. Other corporate expense-net includes items such as net costs related to limited unallocated corporate staff and centrally managed material resource centers of expertise costs, corporate philanthropic activity, and other net costs that 3M may choose not to allocate directly to its business segments. Other corporate expense-net also includes costs and income from contract manufacturing, transition services and other arrangements with the acquirer of the former Drug Delivery business following its 2020 divestiture. Items classified as revenue from this activity are included in Corporate and Unallocated net sales. Because Corporate and Unallocated includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis. 3M Company and Subsidiaries BUSINESS SEGMENTS - (CONTINUED) (Unaudited) -- 13 of 13 --